Enhancing Differential Diagnosis Related to Oxidative Stress, Nitrous Oxide, and Nutrition by Rapid Plasma Homocysteine Measurement.

homocysteine immunoanalysis mass spectrometry neurology nitrous oxide nutrition oxidative stress vitamin B12

Journal

Journal of xenobiotics
ISSN: 2039-4713
Titre abrégé: J Xenobiot
Pays: Switzerland
ID NLM: 101701430

Informations de publication

Date de publication:
27 Sep 2024
Historique:
received: 11 07 2024
revised: 12 09 2024
accepted: 24 09 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

Historically used as a marker for inherited disorders, the current interest in plasma homocysteine measurement lies in its ability to provide valuable information about the metabolic and nutritional status of patients. Specifically, nitrous oxide (N This study evaluates the performance of a rapid immunoassay technique (Snibe) compared to mass spectrometry (LC-MS/MS) for measuring plasma homocysteine levels in patients with nitrous oxide abuse and non-inherited caused of elevated homocysteine, aiming to enhance differential diagnosis related to oxidative stress. 235 patients from Lille University Hospital were included. EDTA blood samples were collected and analyzed using both rapid immunoassay (Snibe) and LC-MS/MS. Neurological assessment was performed using the peripheral neuropathy disability (PND) score. Firstly, significant elevations in plasma homocysteine levels were observed in patients abusing nitrous oxide measured by LC-MS/MS. Secondly, the immunoassay provided rapid results, essential for early clinical decision-making, but tended to underestimate high values compared to LC-MS/MS. A good correlation was found between the methods for low and moderate values. The immunoassay tended to underestimate high-value samples compared to LC-MS/MS, which is a common problem with the competitive methodology. The rapid immunoassay technique is effective for initial screening and early intervention, aiding in the differential diagnosis of conditions related to oxidative stress. Therefore, it is recommended to use the CLIA method for initial screening and confirm with mass spectrometry if there are abnormal samples. Integrating both techniques can enhance diagnostic accuracy and improve patient outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Historically used as a marker for inherited disorders, the current interest in plasma homocysteine measurement lies in its ability to provide valuable information about the metabolic and nutritional status of patients. Specifically, nitrous oxide (N
OBJECTIVE OBJECTIVE
This study evaluates the performance of a rapid immunoassay technique (Snibe) compared to mass spectrometry (LC-MS/MS) for measuring plasma homocysteine levels in patients with nitrous oxide abuse and non-inherited caused of elevated homocysteine, aiming to enhance differential diagnosis related to oxidative stress.
METHODS METHODS
235 patients from Lille University Hospital were included. EDTA blood samples were collected and analyzed using both rapid immunoassay (Snibe) and LC-MS/MS. Neurological assessment was performed using the peripheral neuropathy disability (PND) score.
RESULTS RESULTS
Firstly, significant elevations in plasma homocysteine levels were observed in patients abusing nitrous oxide measured by LC-MS/MS. Secondly, the immunoassay provided rapid results, essential for early clinical decision-making, but tended to underestimate high values compared to LC-MS/MS. A good correlation was found between the methods for low and moderate values.
CONCLUSION CONCLUSIONS
The immunoassay tended to underestimate high-value samples compared to LC-MS/MS, which is a common problem with the competitive methodology. The rapid immunoassay technique is effective for initial screening and early intervention, aiding in the differential diagnosis of conditions related to oxidative stress. Therefore, it is recommended to use the CLIA method for initial screening and confirm with mass spectrometry if there are abnormal samples. Integrating both techniques can enhance diagnostic accuracy and improve patient outcomes.

Identifiants

pubmed: 39449416
pii: jox14040075
doi: 10.3390/jox14040075
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1332-1342

Auteurs

Guillaume Grzych (G)

CHU Lille, Service Biochimie Automatisée-Protéines, F-59000 Lille, France.

Farid Zerimech (F)

CHU Lille, Service Hormonologie Métabolisme Nutrition Oncologie, F-59000 Lille, France.

Benjamin Touze (B)

CHU Lille, Service Biochimie Automatisée-Protéines, F-59000 Lille, France.

Clarence Descamps (C)

CHU Lille, Service Biochimie Automatisée-Protéines, F-59000 Lille, France.

Marie-Adélaïde Bout (MA)

CHU Lille, Service Hormonologie Métabolisme Nutrition Oncologie, F-59000 Lille, France.

Marie Joncquel (M)

CHU Lille, Service Hormonologie Métabolisme Nutrition Oncologie, F-59000 Lille, France.

Claire Douillard (C)

CHU Lille, Service d'Endocrinologie et des Maladies Métaboliques, Reference Center for Inherited Metabolic, F-59000 Lille, France.

Isabelle Kim (I)

CHU Lille, Service Biochimie Automatisée-Protéines, F-59000 Lille, France.

Céline Tard (C)

CHU Lille, Service Neurologie U1172, Centre de Référence des Maladies Neuromusculaires Nord/Est/Ile-de-Frace, F-59000 Lille, France.

Thierry Brousseau (T)

CHU Lille, Service Biochimie Automatisée-Protéines, F-59000 Lille, France.

Classifications MeSH